Cite
HARVARD Citation
Li, Z. et al. (2021). Appearance of an ALK mutation conferring resistance to crizotinib in non–small cell lung cancer harboring oncogenic ROS1 fusion. Lung cancer. pp. 174-175. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, Z. et al. (2021). Appearance of an ALK mutation conferring resistance to crizotinib in non–small cell lung cancer harboring oncogenic ROS1 fusion. Lung cancer. pp. 174-175. [Online].